Testing a faster Ebola and Lassa virus diagnostic
Part of Infections clinical trials.
This study checks a new, faster test for Ebola and Lassa viruses using stored blood samples from past infections. It compares the new test's results with the original diagnosis to see if the quick test is accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a past infection with Ebola virus (EBOV) or Lassa virus (LASV) — or you must have not been infected at all, as a comparison.
- A stored blood sample from that time must be available for lab testing.
- The sample must already have been tested and confirmed as positive or negative for the virus.
- You do not need to be currently sick — these are tests on stored samples only.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a new Ebola test works using blood samples stored from past patients. It may help improve future diagnosis and treatment of Ebola.
This trial tests an investigational vaccine to prevent Lassa fever, a serious illness found in parts of West Africa. People in different age groups will get the vaccine or a placebo and be followed to see if it’s safe and helps the immune system respond.
This trial is developing a quick, point-of-care diagnostic test for Crimean-Congo hemorrhagic fever (CCHF), a serious viral illness. If you have symptoms and are being tested for CCHF, this study could help confirm the diagnosis faster.
This trial tests different combinations of antiviral drugs (favipiravir, ribavirin, and a steroid called dexamethasone) in adults hospitalized with Lassa fever. The goal is to find the safest and most effective treatment.
This trial tests whether adding dexamethasone, a steroid that reduces inflammation, to standard care can help people with severe Lassa fever. It is for adults who are very sick with confirmed Lassa fever.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
Hear when a new Ebola Hemorrhagic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.